Chemed Corporation (CHE)
$
615.32
+9.62 (1.56%)
Key metrics
Financial statements
Free cash flow per share
24.7739
Market cap
9 Billion
Price to sales ratio
3.6865
Debt to equity
0.1259
Current ratio
1.3817
Income quality
1.3824
Average inventory
9 Million
ROE
0.2546
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The net total of other income and expenses is $32,972,000.00 reflecting non-core financial activities. The total costs and expenses for the company are $2,064,794,000.00 reflecting its overall spending. Additionally, the net income ratio is 0.12 reflecting the company's profitability margin. The company earned an interest income of $14,610,000.00 showcasing its financial investments. It operates in two segments: VITAS, focused on healthcare services, and Roto-Rooter, which provides plumbing and related services. The company's stock is identified with the symbol 'CHE' in the market, representing its presence within the competitive landscape. With its foundation dating back to 1970 and headquartered in Cincinnati, Ohio, Chemed Corporation continues to adapt and thrive in its service offerings. The stock is priced at $616.42 positioning it in the higher-end market, indicative of its perceived value among investors. However, the stock has a low average trading volume of 107,668.00 indicating lower market activity, which may suggest a niche interest. With a mid-range market capitalization of $9,006,254,244.00 the company is a steady performer in the financial landscape. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape and ensuring a diverse range of service offerings. Furthermore, it belongs to the Healthcare sector, driving innovation and growth within its fields of expertise while maintaining a solid reputation among its peers and stakeholders.
What is Chemed Corporation (CHE)'s stock forecast?
Analysts predict Chemed Corporation stock to fluctuate between $512.12 (low) and $639.61 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Chemed Corporation's market capitalization?
As of 2025-04-01, Chemed Corporation's market cap is $9,006,254,244, based on 14,636,700 outstanding shares.
How does Chemed Corporation compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Chemed Corporation has a Lower Market-Cap, indicating a difference in performance.
How can I buy Chemed Corporation (CHE) stock?
To buy Chemed Corporation (CHE) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CHE. Place an order (Market, Limit, etc.).
What is the best time to invest in Chemed Corporation?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Chemed Corporation perform in the last earnings report?
Revenue: $2,431,287,000 | EPS: $20.10 | Growth: 10.99%.
Where can I find Chemed Corporation's investor relations reports?
Visit https://www.chemed.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Chemed Corporation?
You can explore historical data from here
What is the all-time high and low for Chemed Corporation stock?
All-time high: $654.62 (2024-03-15) | All-time low: $403 (2021-10-12).
What are the key trends affecting Chemed Corporation stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
businesswire.com
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 35th Annual Healthcare Conference on Monday, March 17, 2025, at approximately 9:20 a.m. (ET). The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be acce.
zacks.com
CHE's earnings and revenues beat estimates in the fourth quarter of 2024.
seekingalpha.com
Chemed Corporation (NYSE:CHE ) Q4 2024 Earnings Conference Call February 27, 2025 10:00 AM ET Company Participants Holley Schmidt – Assistant Controller Kevin McNamara – President and Chief Executive Officer Mike Witzeman – Chief Financial Officer Nick Westfall – Chairman and Chief Executive Officer, Chemed VITAS Healthcare Corporation Conference Call Participants Michael Murray – RBC Capital Markets Christian Porter – Bank of America Operator Hello, and welcome to the Chemed Corporation Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
zacks.com
Chemed (CHE) came out with quarterly earnings of $6.83 per share, beating the Zacks Consensus Estimate of $6.79 per share. This compares to earnings of $6.60 per share a year ago.
businesswire.com
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company's capital stock, payable on March 14, 2025, to shareholders of record as of February 24, 2025. This is equal to the dividend paid in December 2024. This represents the 215th consecutive quarterly dividend paid by Chemed in its 53 years as a public company. Listed on the New York Stock Exchange and headquartered in Cinc.
See all news
